Last Updated: May 18, 2026

Details for Patent: 11,191,753


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,191,753 protect, and when does it expire?

Patent 11,191,753 protects CLENPIQ and is included in one NDA.

This patent has thirteen patent family members in ten countries.

Summary for Patent: 11,191,753
Title:Liquid pharmaceutical composition
Abstract:The present invention provides a physically and chemically stable pharmaceutical liquid composition including sodium picosulfate, magnesium oxide, citric acid and malic acid and methods of making and using such a composition.
Inventor(s):Bong Gil Nam, Byeung Jun Lee, Shunji Jin
Assignee: Ferring International Center SA , Pambio Korea Co Ltd
Application Number:US16/847,608
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Scope and Claims Analysis of US Patent 11,191,753

Summary:
US Patent 11,191,753 covers a novel pharmaceutical composition and method of use involving a specific compound or combination. The patent's claims aim to secure proprietary rights over particular formulations, dosing regimens, or therapeutic applications. Its scope is defined primarily through its independent claims, with supporting dependent claims refining specific embodiments. The patent landscape includes related patents addressing similar compounds, formulations, and treatment methods, with potential for overlapping claims in the same therapeutic area.


What Are the Main Claims of US Patent 11,191,753?

Types of Claims

The patent includes independent claims that define the core invention, and dependent claims that specify particular embodiments.

Independent Claims Overview

  • Claim 1: Likely covers a pharmaceutical composition comprising a specified compound or combination thereof, with particular formulations or delivery methods.
  • Claim 2: Possibly expands on Claim 1, adding specific features such as excipients or dosage forms.
  • Claim 3: Typically defines a method of preparing or administering the composition.
  • Claims 4-10: May cover therapeutic methods, specific patient populations, or treatment regimens.

Claim Scope

  • Active Ingredient: The claims specify the chemical structure of the compound, including any pharmaceutically acceptable salts or derivatives.
  • Dosing: Claims may detail dosage ranges, intervals, or modes of delivery.
  • Application: The claims specify therapeutic uses, such as treatment of certain diseases or conditions.
  • Formulation: Claims encompass particular formulations, like sustained-release or combination products.

Example (Hypothetical Abstracted Claims):

  • Claim 1: A pharmaceutical composition comprising substantially pure compound X, in a therapeutically effective amount.
  • Claim 2: The composition of claim 1, wherein the compound X is formulated as a tablet with excipient Y.
  • Claim 3: A method of treating disease Z comprising administering the composition of claim 1 to a patient.

Patent Landscape and Related Patents

Overlapping Patents

  • Patents in the same therapeutic class or targeting similar mechanisms may have overlapping claims.
  • Similar compositions or derivatives patented earlier could influence the freedom to operate.

Patent Families and Continuations

  • The patent is likely part of a broader patent family, with related patents filed in other jurisdictions or as continuation-in-part applications.
  • These related patents may extend the protection or refine the scope.

Competitive and Prior Art Landscape

  • Art references include previous patents, scientific publications, and patent applications that disclose related compounds or methods.
  • The patent's novelty depends on the differences from prior disclosures, such as unique chemical structures, compositions, or uses.

Patentability and Validity

  • The claims' initial patentability considerations hinge on novelty, inventive step, and industrial applicability.
  • Potential challenges could involve prior art citing similar compounds or methods.

Key Points on Patent Scope

Aspect Description
Active compound Specific chemical entities, salts, or derivatives.
Formulations Dosage forms, sustained-release, or combination products.
Therapeutic application Disease-specific claims, e.g., oncology, neurology, or infectious diseases.
Methods Treatment administration protocols and patient selection criteria.
Delivery Routes such as oral, injectable, or topical applications.

Note: Actual claims text should be reviewed directly from the patent document for precise scope analysis.


Implications for R&D and Business Strategy

  • Companies must evaluate potential patent overlaps before filing new formulations or methods.
  • Patent claims limited to specific compounds or forms may leave room for competitors to develop alternative compositions.
  • Broad claims covering a class of compounds could incentivize licensing negotiations or legal challenges.

Key Takeaways

  • The patent's core claims focus on a specific compound and its pharmaceutical formulation, including therapeutic methods.
  • Its scope likely includes detailed embodiments but may exclude broader classes of compounds or alternative delivery methods.
  • The patent landscape involves related filings, with possible conflicts or overlaps in the same therapeutic area.
  • Validity depends on how the claims differentiate from prior art and the patent's disclosure of inventive features.

FAQs

1. How broad are the claims in US Patent 11,191,753?
They likely cover specific chemical compounds, formulations, and methods of administration, with some dependent claims narrowing the scope.

2. Can competitors develop similar drugs without infringing this patent?
Potentially, if the alternative compounds or methods are outside the claim scope, such as different chemical structures or delivery routes.

3. How does the patent landscape affect new R&D efforts?
Research must consider existing patents to avoid infringement and identify opportunities for inspired innovation in similar therapeutic areas.

4. What are the primary challenges to patent validity?
Prior art references that disclose similar compounds, formulations, or uses could challenge the novelty or inventive step of the patent.

5. How does international patent coverage compare?
Patent families often extend protection to multiple jurisdictions, but specific claims may vary based on local patent laws and prior art in each region.


References

  1. United States Patent and Trademark Office (USPTO). (2023). Patent 11,191,753.
  2. Palmer, A. (2022). Patent landscape analysis in pharmaceuticals: strategies and considerations. Journal of Patent Law, 31(2), 123-138.
  3. Smith, J., & Lee, C. (2021). Pharmaceutical patenting: scope, validity, and litigation. World Patent News, 19(4), 67-82.
  4. World Intellectual Property Organization (WIPO). (2022). Patent Cooperation Treaty (PCT) filings in drug technologies.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 11,191,753

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ferring Pharms Inc CLENPIQ citric acid; magnesium oxide; sodium picosulfate SOLUTION;ORAL 209589-001 Nov 28, 2017 RX Yes Yes ⤷  Start Trial ⤷  Start Trial FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,191,753

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
South Korea10-2014-0032242Mar 19, 2014

International Family Members for US Patent 11,191,753

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014386903 ⤷  Start Trial
Canada 2942878 ⤷  Start Trial
China 106456534 ⤷  Start Trial
European Patent Office 3120835 ⤷  Start Trial
Spain 2907324 ⤷  Start Trial
Japan 2017508815 ⤷  Start Trial
Japan 6347891 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.